Shigella

9,451views

Shigella

Exam 2 - AHN 548

Exam 2 - AHN 548

The flu vaccine: Information for patients and families
Vaccinations
Vaccinations: Clinical
Protein synthesis inhibitors: Aminoglycosides
Antituberculosis medications
Protein synthesis inhibitors: Tetracyclines
Antimetabolites: Sulfonamides and trimethoprim
Miscellaneous cell wall synthesis inhibitors
Cell wall synthesis inhibitors: Penicillins
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Fluoroquinolones
Miscellaneous protein synthesis inhibitors
DNA synthesis inhibitors: Metronidazole
Mechanisms of antibiotic resistance
Bites and stings: Clinical
Antimalarials
Francisella tularensis (Tularemia)
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Hypersensitivity skin reactions: Clinical
Hypersensitivity pneumonitis
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Varicella zoster virus
Cytomegalovirus
Epstein-Barr virus (Infectious mononucleosis)
Human herpesvirus 8 (Kaposi sarcoma)
Herpes simplex virus
Human herpesvirus 6 (Roseola)
Adenovirus
Parvovirus B19
Human papillomavirus
Poxvirus (Smallpox and Molluscum contagiosum)
BK virus (Hemorrhagic cystitis)
JC virus (Progressive multifocal leukoencephalopathy)
Hepatitis A and Hepatitis E virus
Hepatitis D virus
Influenza virus
Mumps virus
Respiratory syncytial virus
Measles virus
Human parainfluenza viruses
Dengue virus
Zika virus
West Nile virus
Yellow fever virus
Hepatitis C virus
Norovirus
Rotavirus
HIV (AIDS)
Human T-lymphotropic virus
Ebola virus
Rabies virus
Rubella virus
Eastern and Western equine encephalitis virus
Lymphocytic choriomeningitis virus
Hantavirus
Prions (Spongiform encephalopathy)
Protease inhibitors
Chlamydia pneumoniae
Chlamydia trachomatis
Coccidioidomycosis and paracoccidioidomycosis
Histoplasmosis
Blastomycosis
Pneumocystis jirovecii (Pneumocystis pneumonia)
Candida
Mucormycosis
Aspergillus fumigatus
Sporothrix schenckii
Cryptococcus neoformans
Malassezia (Tinea versicolor and Seborrhoeic dermatitis)
Plasmodium species (Malaria)
Babesia
Giardia lamblia
Entamoeba histolytica (Amebiasis)
Cryptosporidium
Acanthamoeba
Naegleria fowleri (Primary amebic meningoencephalitis)
Toxoplasma gondii (Toxoplasmosis)
Trypanosoma brucei
Trypanosoma cruzi (Chagas disease)
Trichomonas vaginalis
Leishmania
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Hepatitis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Herpesvirus medications
Azoles
Echinocandins
Miscellaneous antifungal medications
Anthelmintic medications
Anti-mite and louse medications
Pediatric lower airway conditions: Clinical
Pediatric infectious rashes: Clinical
Poliovirus
Knowledge Shot: What is acute flaccid myelitis, the polio-like paralyzing disease
Staphylococcus aureus
Staphylococcus epidermidis
Staphylococcus saprophyticus
Enterococcus
Streptococcus agalactiae (Group B Strep)
Streptococcus pneumoniae
Streptococcus viridans
Clostridium perfringens
Clostridium botulinum (Botulism)
Clostridium tetani (Tetanus)
Clostridium difficile (Pseudomembranous colitis)
Bacillus anthracis (Anthrax)
Corynebacterium diphtheriae (Diphtheria)
Listeria monocytogenes
Infective endocarditis: Clinical
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Salmonella typhi (typhoid fever)
Shigella
Escherichia coli
Vibrio cholerae (Cholera)
Brucella
Yersinia pestis (Plague)
Neisseria gonorrhoeae
Mycobacterium tuberculosis (Tuberculosis)
Treponema pallidum (Syphilis)
Borrelia burgdorferi (Lyme disease)
Leptospira
Streptococcus pyogenes (Group A Strep)

Transcript

Watch video only

Shigella is a Gram-negative bacterium that belongs to the Enterobacteriaceae family.

There are 4 species of Shigella:

S. dysenteriae, S. flexneri; S. boydii; and S. sonnei, and each has its own serotypes.

In humans these species can all cause Shigellosis, which is a contagious infection of the intestines, particularly the colon.

And shigellosis can progress to dysentery, which is when the infection causes inflammation of the colon, resulting in severe abdominal pain and diarrhea.

Now, Shigella is a gram-negative, rod shaped bacterium, meaning it looks like a little red or pink stick on a gram stain.

And it’s a facultative anaerobe, so it can survive with or without oxygen in the environment.

It has no flagellum, making it nonmotile; and it doesn’t form spores.

It’s also a non-lactose fermenter, so it doesn’t ferment lactose; and it’s urease and oxidase-negative, meaning it doesn’t produce these enzymes.

Finally, it doesn’t produce hydrogen sulfide gas either, and this can be used to selectively identify Shigella on special culture mediums like MacConkey agar.

On this medium, Shigella mostly forms white, non-lactose fermenting, non-hydrogen sulfide-producing colonies

Now, once Shigella is ingested, it multiplies in the small intestine, and then passes into the colon.

There, it targets the epithelial layer of the mucosal lining where it infects colonic enterocytes and microfold cells, or M-cells.

And these M-cells phagocytose, which means they eat the bacteria from the intestinal lumen, and then spit it out into the underlying mucosa-associated lymphoid tissues, or MALTs.

MALTs are a type of mucosal immune tissue that extends into the submucosa, and contains plenty of immune cells like macrophages.

The macrophages gobble up Shigella to neutralize the pathogen, but the bacterium induces apoptosis, or programmed cell death, in the macrophage.

Now, when a macrophage dies, it releases a variety of cytokines, including IL-1β, which activates an intense inflammatory process that recruits additional immune cells to wage war at the site of infection.

And this results in the death of epithelial cells, which damages the colonic mucosa, resulting in ulcerations and abscesses.

All the damage and migration of immune cells, particularly polymorphonuclear leukocytes, through the epithelium disrupts the cellular junctions between neighboring epithelial cells, allowing Shigella from the intestinal lumen to enter enterocytes through the lateral sides of the cell.

And actually, that’s not the only way Shigella can infect enterocytes after the initial infection:

After Shigella kills the macrophage and is released into the immune tissue under the epithelium, it can access and infect colonic enterocytes from their basal side.

Shigella uses its type III secretory system, which acts almost like a syringe, to puncture and inject proteins into enterocytes that makes the enterocytes phagocytose Shigella.

So that means Shigella is slowly engulfed by the cell membrane, forming a membrane bound compartment that eventually pinches off from the cell membrane and ends up inside the cell, where it’s called a phagosome.

Then, Shigella can use a number of effector proteins, which lyse the phagosome and release Shigella into the cytoplasm.

In the cytoplasm, effector proteins also induce Shigella’s actin-based motility.

This starts by recruiting the host cell’s small actin filaments to one end of the bacteria.

And as more and more actin filaments get recruited and polymerize behind the bacteria’s end pole, that propels the bacteria forward, like a rocket.

That helps Shigella “blast” through the lateral sides of both the host enterocyte and, after, the neighboring enterocyte, further spreading the infection.

Finally, one particular species of Shigella, S. dysenteriae serotype 1, also produces Shiga toxin.

Shiga toxin, similar to the shiga-like toxin producing pathotype of E. coli, is an AB toxin, so it has two main subunits, A and B, that are joined by a disulfide bond.

Each subunit plays a specific role in the invasion and destruction of a host cell.

The B subunit helps bind the toxin to the host’s cell membrane, where the toxin is ultimately engulfed into a phagosome.

Within the host’s cell cytoplasm, the inside of the phagosome becomes more acidic, and as a consequence, the disulfide bond holding the two subunits together becomes weak and eventually break, separating the subunits.

At this point, the A subunit can then diffuses through the phagosome membrane into the cytoplasm, where it targets the ribosomes.

In eukaryotic cells, ribosomes are made of two main subunits; the larger of the two is the 60S subunit, and it contains a 28S rRNA protein that’s important for the initiation of polypeptide synthesis.

Key Takeaways

Shigella is a genus of bacteria known to cause a contagious form of gastroenteritis known as shigellosis. Shigellosis is characterized by an inflammation of the gastrointestinal tract, which causes destruction and inflammation of the epithelium, leading to dysentery with symptoms like severe abdominal and rectal cramping and pain, a fever, and watery diarrhea with mucous with or without blood or pus. Shigella is transmitted through the fecal-to-oral route, mainly through fingers, food, and flies. It's diagnosed with a fecal sample and treatment centers around fluid and electrolyte replenishment and antibiotics.